Anaesthetists who care for severely injured trauma patients, or patients sustaining massive intraoperative blood loss, may be required to infuse large volumes of fluids and blood products rapidly in order to restore circulating blood volume. Rapid infusion of unwarmed crystalloid and blood may result in considerable lowering of core temperature that may cause cardiac arrhythmias, coagulopathy, major alterations in response to pharmacological agents, and has been associated with increased mortality. 1-5 Therefore, most clinicians advocate the use of CAN J ANAESTH 1995 / 42:7 / pp 636-42 
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Anaesthetists who care for severely injured trauma patients, or patients sustaining massive intraoperative blood loss, may be required to infuse large volumes of fluids and blood products rapidly in order to restore circulating blood volume. Rapid infusion of unwarmed crystalloid and blood may result in considerable lowering of core temperature that may cause cardiac arrhythmias, coagulopathy, major alterations in response to pharmacological agents, and has been associated with increased mortality. 1-5 Therefore, most clinicians advocate the use of warmed /v fluids during fluid resuscitation of hypovolaemic patients in shock. Several methods to warm /v fluids have been evaluated. 6,7 These include immersing coiled/v tubing in warm water bath, passing the/v tubing through heating blocks (dry heat technology), and passing the/v tubing through a conductive surface interfaced with a counter-current heated water bath. The ability of blood warmers to deliver normothermic fluids rapidly may be limited by several factors including limited heat transfer capability of materials such as plastic, limited surface area of the heat exchange mechanism, inadequate heat transfer of the exchange mechanism at high flow rates, heat loss after the/v tubing leaves the warmer, and suboptimal flow rates due to high resistance of tubing. 6,7 Because the 40~ water bath temperature of countercurrent fluid warmers exceeded the American Association of Blood Bank standards of 38~ the Department of Pathology and Transfusion Medicine at our institution was unable to allow the purchase of these counter-current devices for operating room use. Therefore, the Department of Anesthesia, in conjunction with a cardiac perfusionist, developed a modified cardioplegia heat exchange device for rapid intraoperative infusion of crystalloid and blood. The purpose of the present study was to compare the fluid warming capabilities and flow rates of this modified heat exchanger with two commercially available blood warmers at our institution, and one commercially available counter-current heat exchange wanner that had been obtained by another Department. Two common clinical conditions were simulated-pressure driven infusion, and gravity driven infusion with the roller clamp wide open.
Methods
The commercially available dry heat technology blood warmers tested were those currently in use at our institution, and consisted of the Astotherm (Stihler Electronic Geub, D7000, Stuggart, Germany, Figure 1 Table  I . Fluids tested were red cells, red cells diluted with saline 0.9% 200 ml, and crystalloid (saline 0.9% or lactated Ringers', 1 L bags). All red cells were obtained from outdated standard blood bank supply, had been collected in Adsol and were kept refrigerated until use. All crystalloid solutions were at room temperature. In order to simulate the clinical condition of hypovolaemic shock, the entire bag of fluid was infused under constant 300 IV fluid to be I transfused
Illil Heat Exchanger
FilterAir Eliminator To patient FIGURE 3 Schematic of the Level 1 System 250 warmer. The device consisted of a heater that warmed water to 40~ and circulated it through a pump and heat exchange segment with a central tube for water flow. Fluid flowed through the outer sheath which surrounded the water core. Note the falter and air eliminator distal to the heat exchanger. mmHg pressure using a pressure bag (Disposable Pressure Infusor, Vital Signs Inc., Totowa, N J) connected to a constant pressure device (ToLmiaster TS2000, Biomedical Dynamics, Burnsville, MN). Each bag of fluid completely infused was considered one fluid run. Fluids were also infused with the roller clamp in the wide open position, but not under pressure (gravity flow, height of column = 1.83). Temperature measurements were made before the fluid entered the warmer (inlet) and at the end of the/v tubing (outlet or point where tubing would be attached to the patient), using rapid-acting in-line Shiley thermistor probes (Shiley Inc., Irvine, CA) that did not obstruct the flow. Temperature probes were calibrated by the manufacturer using standards traceable to the National Bureau of Standards, and were accurate to -4-0. I~ Fluid was infused into cylindrical scored beakers of varying sizes (10-3000 ml). For each fluid run, inlet and outlet temperatures, and volume of fluid were measured every 10-20 see for a total of ten measurements or until the bag was empty, whichever came first. Room temperature (Monotherm Model 6510, Mallincrodt Medical, St Louis, MO) was recorded for each fluid run. Minute flow rates were calculated for each measurement interval. Flow rates and temperatures were compared between warmers for each fluid type using analysis of variance (GLM procedure, SAS software), with Tukey's test for multiple comparisons. Results are mean values 5: SD. A P value < 0.05 was considered significant.
Results
A total of 108 runs and 767 measurements were done for the warmers as follows: Astotherm -30 runs, 243 measures; Flotem -14 runs, 123 measures; System 250 -27 runs, 180 measures; modified heat exchanger -37 runs, 221 measures. There were 48 runs with pressure driven infusion and 60 runs with gravity driven infusion. The number of flow rate and temperature measurements per run was 7.4 + 3.2 for fluids under pressure and 6.8 + 2.8 for gravity infusion. A total of 40 units of red ceils were tested with a haematocrit of 65.9 + 9.5%. The average age of the red ceils at time of use was 65.4 -t-9.3 days. The room temperature was 21 + 0.9~ (range 19.4-22.7~
Temperature of crystalloid before the warmer (inlet temperature) was 21.0 + 1.1~ Corresponding values for diluted and undiluted red cells were 17.0 + 2.8 and 13.6 + 4.5~ respectively. For fluids under pressure, flow rates were faster for each fluid type with the modified heat exchanger and System 250 than with the Astotherm and Flotem devices (P < 0.05, Table  II , III). At these high flow rates, only the modified heat exchanger and System 250 were capable of delivering warm fluids (outlet temperatures >32~ However, no blood warmer was capable of delivering fluids at normothermia (> 36.5 ~ C, Table IV, V) . With wide open gravity flow, flow rates were faster with the System 250 and modified heat exchanger compared with the other two warmers (P < 0.05, Table IV ).
Discussion
The present study was designed to simulate two scenarios that clinicians are likely to encounter. In the first, the patient presents with severe circulatory shock due to massive preoperative or intraoperative blood loss. Massive fluid resuscitation via large-bore /v cannulas (e.g., 8.5 French) is necessary in order to prevent acidosis and irreversible shock. In the second, the fluid and blood volume deficit is not as severe, although ongoing blood loss may necessitate moderately fast infusions with the roller clamp wide open to maintain normovolaemia and haemodynamic stability.
In the fLrst scenario, it is customary to deliver/v crystalloid fluids under pressure immediately in order to restore circulation rapidly. Blood products are given as necessary. At our institution, one litre bags of lactated Ringers' or normal saline are stored at room temperature. Therefore, we chose room temperature as the starting temperature for crystaUoid solutions. In the case of massive transfusion, blood is almost always diluted with 100-200 ml normal saline at room temperature, after proper identification 6f patient and donor information for compatibility. This necessitates a certain time out of the refrigerator, such that the temperature at the start of blood for most transfusions is I0-15~ Pressure driven infusions of crystalloids using the Astotherm and the Flotem devices were capable of delivering approximately 250 ml. min -t, or 15 L. hr -t, with little heat transfer (outlet temperatures <25~
Infusion of 15 L of 25~ crystalloid represents a negative thermal shift of about 180 kcals (thermal shift = V • (T37 -T.~, where V is the volume of fluid infused or 15 L in this example, and T37 -Ti is the temperature difference between the infused fluids (25~ and 37~ or 12~ in this example). 8 This will result in a decrease in core temperature by about 3 ~ C in a 70 kg patient (temperature decrease = thermal shift/specific heat )< body weight; in this example thermal shift was -180 kcal, specific heat of the body was assumed to be 0.83 kcal). 1,9 It is likely that the negative thermal shift may be even greater for cold blood than for cold crystalloid solutions, although the net effect of infusing cold solutions in the body depends on several factors including tissue blood flow, temperature gradients within the body, rate of change of temperature within the body, rate of body heat generation, rate of heat loss to the environment, specific heat of the infused solution and specific heat of the body. 2 Compared with the Astotherm and Flotem devices, both the System 250 and the modified heat exchanger were capable of delivering considerably warmer cystalloid fluid (33 and 35~ respectively) at a much faster rate (612 and 740 ml. min -I, respectively). Assuming the same 15 L fluid requirement, the expected decrease in core temperature in a 70 kg patient from infusion of these large amounts of crystalloid would be less (negative thermal shift of 15 L )< 37-34, or -45 kcal), in the order of 0.75~ (-45 keal/0.83 X 70). Pressure driven flow rates of diluted red cells were faster than that of undiluted red cells, but slower than that of crystalloid for all fluid warmers tested. Thus, the practice of diluting red cells with 200 ml 0.9% saline (at room temperature) can improve flow rates, as well as increase inlet temperature of the red cells to be transfused.
In the second scenario, gravity driven crystaUoid infusions with the roller clamp wide open using the Astotherm and the Flotem device resulted in flow rates of approximately 90 ml. rain -I or 5.4 L. hr -I, with outlet temperatures of 30 and 27~ respectively. To heat 5.4 L of crystalloid from 28 to 37~ would require 38 kcal (5.4 • (37-28), which could decrease core temperature by about 0.83~ in a 70 kg patient. Compared with the Astotherm and Flotem devices, both the System 250 and the modified heat exchanger were capable of delivering warmer crystaUoid fluid (36 and 35~ respectively) at a much faster rate (270 and 290 ml. min-l, respectively). Assuming the same 5.4 L fluid requirement, the expected decrease in core temperature would be negligible. Gravity driven flow rates of diluted and undiluted red cells were lower compared with crystalloid for all fluid warmers tested. At these lower flow rates, the performance of the System 250 was better for both diluted and undiluted red cells compared with the modified heat exchanger and the other devices. It is likely that heat loss along the tubing accounted for the decreased efficiency of the modified heat exchanger at flow rates <( 120 ml. rain -~. Thus, the Astotherm warmer was more effective than the modified heat exchanger in delivering warm diluted red cells (outlet temperature: 31.6~ vs 29.2~ flow rate 43 ml. rain -~ vs 99 ml. min -1, respectively, Table IV, V). However, at lower flow rates with the Astotherm device (6 ml. min-t), there was considerable loss of heat at low flow rates such that the outlet temperature approached that of the room (Table IV, V) .
Previous studies evaluating blood warmer performance have focused on the ability of the warmers to heat cold refrigerated fluids. 7,t~ However, it is our experience that the starting temperature of crystalloid solutions and diluted red cells used for fluid resnscitation in clinical practice were consistently warmer than the refrigeration temperature. Therefore, it was not surprising that the warming capabilities of the System 250 for crystalloid solutions at 600 ml. min -I in the present study were greater than those reported previously, 7,j~ because the starting temperature of these solutions was that of the room, and not of the refrigerator. Despite the relatively warm inlet temperature for diluted cells (17~ the Flotem was still inadequate at delivering warm red cells, although the Astotherm was capable of warming diluted red cells to between 31 and 32~ Presson et al. recommended that flow rates of cold blood through the System 250 be restricted to 250 ml. mill -t because warming was inadequate above this rate. ~0 Our data suggest that this recommendation will be easily met since the average pressure driven flow capacity of diluted red cells through the System 250 was approximately 200 ml-min-~, which resulted in outlet temperatures of about 33~
The ideal fluid warmer should be capable of safely delivering fluids and blood products at normothermia at both high and low flow rates. It is clear from the present study that none of the fluid warmers tested was able to deliver consistently fluids at 37~ despite the use of countercurrent heat exchange mechanisms and water bath temperatures of 40~ Indeed, it is the authors din- for up to two hours in constant-temperature waterbath, and showed that even subtle alterations in red cell integrity were not apparent until 46~ Thus, efficient blood warmers using 42 ~ C waterbaths should not damage red cells, and should result in more normothermic fluid delivery in the near future. Incorporation of tubing between the warming unit and the patient to warm the /v fluids (Hotline device, Level 1 Technologies) has been shown to reduce heat loss effectively along the tubing which can occur at flow rates <75 ml. min -~ with the System 250. ~3
Although the modified heat exchange device was able to deliver pressure driven fluids between 33 and 35~ at a much faster rate than the System 250 device, routine use of this modified cardioplegia device over the System 250 cannot be recommended because it took more time to set up, was harder to debubble, had higher disposable costs, and required a separate filter for blood products. Moreover, the commercially available System 250 was capable of delivering 5 L of diluted red cells (approximately one blood volume in a 70 kg patient) within 25 min, 15 L of crystalloid in 25 min, and was associated with higher outlet temperatures than the modified heat exchanger at gravity drive flow rates of approximately 100 ml. min -j (diluted red cells: 35.4 vs 29.2~ P < 0.05). Note that the flow rates generated in the present study were assumed to be unimpeded, as is the case of a large bore catheter such as an 8.5 French introducer. Indeed, with the System 250 or modified heat exchanger, a single large bore catheter is all that is needed for most fluid resuscitations. Because of the high flow rates generated by these warmers when used with constant pressure devices, the limiting factor in fluid resuscitation is the time required to identify red cell donor and recipient information, spike and hang the fluid and insure absence of air from the fluid system. In the authors' experience, it is wise to have one individual solely responsible for pressurized infusion of fluids. This individual must utilize extreme vigilance and caution because of the danger of infusing air at these high flow rates. We know of four cases of massive air embolus at other institutions following the use of pressurized infusions. Therefore, it is our opinion that constant pressurized infusion devices not be used unless the patient is in hypovolaemic or haemorrhagic shock, and all air has been removed from the fluid to be rapidly infused. The automatic air eliminator incorporated into the design of the System 250 makes this unit (and subsequent updated units such as the System 500 and newer disposables) somewhat safer, but does not eliminate the risks of massive air embolus. Because of the inadequate outlet temperatures, we cannot recommend Flotem warmers for any perioperative use. Indeed, based on the present study and that of Uhl et al. 7 that documented the inadequacies of fluid warmers utilizing dry heat technology, Flotem and Astotherm devices are almost never used in the perioperative setting, and have been replaced at our institution by fluid warming devices using countercurrent heat exchange technology.
In summary,/v infusion of large volumes of cold and room temperature solutions may contribute to hypothermia, which in turn may cause coagulopathy, myocardial ischaernia, shivering, and cardiac arrhythmias. 1-534 The System 250 and the modified heat exchanger, which use countercurrent heat exchange mechanisms where a heater warms water to 40 ~ C and circulates it via a pump were moderately effective (outlet temperature >32~ in warming crystalloid and red cells at pressure driven and gravity driven flow rates. The System 250 was superior to the other three devices in warming diluted and undiluted red cells at gravity driven wide open flow rates (outflow temperature 33-35~
The Flotem and Astotherm warmers, which use dry heat technology, were not effective in warming rapidly infused solutions, although the Astotherm was moderately effective in warming red cells at lower flows (40-45 rnl-min -l, outlet temperatures 31-32~
Under the conditions of the present study, none of the warmers tested was able to deliver fluids at normothermia.
